Insights On Partnering

  1. A Proactive Approach To Ebola Vaccine Development

    Best practices for rapid test development and regulatory approvals.

  2. Fighting Cancer: Biomarkers For Immuno-Oncology Clinical Trials

    Using anatomic pathology for biomarker development in clinical trials can help predict and assess how a patient will respond to immuno-oncology therapies

  3. Minimal Residual Disease: Finding The Right Test For The New Definition Of Remission

    Measurement of Residual Disease for improved oncology trial outcomes - what factors make an MRD test most effective plus explore the pros and cons of various MRD measurement approaches.

  4. Planning And Implementing Biomarker Testing For immuno-Oncology Trials

    Exploring the challenges with the diverse clinical biomarker requirements.

  5. Immunotherapy And PD-L1: The Future Of Precision Medicine

    Advances in precision medicine lead to new trends in immunotherapy.

  6. Using Advanced Techniques For Protein Bioanalysis

    Overcoming hurdles in a regulated setting.

  7. CRO Consolidations – A Boon for Pharma?

    CRO mergers affect the agility and speed of operations and may hamper efforts to bring in new technologies but at the same time can add significant value to both the pharmaceutical industry and the patients who depend on the life-saving medicines it produces.

  8. Collaboration Is The Secret To Successful Outsourcing

    Best practices to ensure a successful sponsor-CRO collaboration

  9. Setting The Scene In Immuno-oncology

    Applying lessons learned to the future of Immuno-oncology.

  10. Don’t Let Burdensome Site Payment Processes Undermine Your Study Performance

    CROs & Sponsors:  Have we overcome the limitations of early site payment solutions? Learn how a Site Payment Advisory Group helped improve site payment technology for all stakeholders.